Concentra Group Holdings Parent (CON) Stock Price, News & Analysis

Company Overview

Concentra Group Holdings Parent, Inc (NYSE: CON) is a U.S.-based specialty finance company focused on the commercial real estate lending sector. The company originates, underwrites and manages a diverse range of real estate-backed loans, including senior first mortgages, mezzanine debt and preferred equity. Through its integrated platform, Concentra consolidates origination, credit approval, portfolio management and loan servicing for commercial properties across major property types, from multifamily and office to hospitality and industrial.

Since its founding in 2001, Concentra has expanded its product offerings to include structured credit vehicles and special servicing capabilities. Its senior loan portfolio is primarily composed of floating- and fixed-rate first mortgages, typically sized between $10 million and $150 million. The firm also sponsors and manages Concentra Investment Trusts, allowing institutional and high-net-worth investors to access diversified pools of commercial real estate debt. Concentra’s special servicing arm provides workout, remediation and enforcement services for distressed or special situation loans, leveraging in-house legal and workout expertise.

Headquartered in Dallas, Texas, Concentra maintains a national origination footprint, collaborating with a network of real estate brokers, property operators and capital partners to structure tailored financing solutions. Its investor base includes pension funds, insurance companies, endowments and family offices seeking direct real estate credit exposure. Over the years, Concentra has grown its managed portfolio to several billion dollars in outstanding commitments, serving projects in primary and secondary markets throughout the United States.

Concentra is led by a senior management team with deep experience in banking, securitization and real estate finance. The firm’s leadership combines backgrounds in investment banking, credit underwriting and portfolio management, underpinning its disciplined approach to risk-adjusted returns. Through a combination of proprietary origination channels and relationships with institutional investors, Concentra continues to refine its platform and expand its foothold in the competitive commercial real estate debt market.

Key Stats

• Today's Range: $19.73 to $20.23
• 50-Day Range: $19.89 to $22.74
• 52-Week Range: $18.89 to $24.81
• Volume: 465,295 shs
• Average Volume: 761,531 shs
• Market Capitalization: $2.59 billion
• P/E Ratio: 15.09
• Dividend Yield: 1.24%
• Price Target: $28.50
• Consensus Rating: Buy

Concentra Group Holdings Parent Stock Analysis - MarketRank™

Concentra Group Holdings Parent scored higher than 58% of companies evaluated by MarketBeat, and ranked 465th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Concentra Group Holdings Parent has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Concentra Group Holdings Parent has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -11.56%

Earnings Growth

Earnings for Concentra Group Holdings Parent are expected to decrease by -11.56% in the coming year, from $1.47 to $1.30 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Concentra Group Holdings Parent is 15.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.26.

Price to Earnings Ratio vs. Sector

The P/E ratio of Concentra Group Holdings Parent is 15.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.28.

Price to Earnings Growth Ratio

Concentra Group Holdings Parent has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Concentra Group Holdings Parent has a P/B Ratio of 9.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CON.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Concentra Group Holdings Parent pays a meaningful dividend of 1.26%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Concentra Group Holdings Parent does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Concentra Group Holdings Parent is 18.66%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Concentra Group Holdings Parent will have a dividend payout ratio of 19.23% next year. This indicates that Concentra Group Holdings Parent will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for CON.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.65

News Sentiment

Concentra Group Holdings Parent has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Concentra Group Holdings Parent this week, compared to 4 articles on an average week.

Search Interest

Only 4 people have searched for CON on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

MarketBeat Follows

2 people have added Concentra Group Holdings Parent to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concentra Group Holdings Parent insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.60% of the stock of Concentra Group Holdings Parent is held by insiders.

CON Stock Analysis - Frequently Asked Questions

How have CON shares performed this year?

Concentra Group Holdings Parent's stock was trading at $19.78 at the beginning of the year. Since then, CON shares have increased by 1.7% and is now trading at $20.1250.

How were Concentra Group Holdings Parent's earnings last quarter?

Concentra Group Holdings Parent, Inc. (NYSE:CON) announced its quarterly earnings data on Wednesday, May, 7th. The company reported $0.32 earnings per share for the quarter, beating analysts' consensus estimates of $0.31 by $0.01. The firm's revenue was up 7.1% compared to the same quarter last year.
Read the conference call transcript.

When did Concentra Group Holdings Parent IPO?

Concentra Group Holdings Parent (CON) raised $529 million in an initial public offering on Thursday, July 25th 2024. The company issued 22,500,000 shares at $23.50 per share.

Who are Concentra Group Holdings Parent's major shareholders?

Top institutional investors of Concentra Group Holdings Parent include Wealth Enhancement Advisory Services LLC (0.01%), Financiere des Professionnels Fonds d investissement inc. (0.01%), Financiere des Professionnels Fonds d investissement inc. (0.01%) and CX Institutional.

How do I buy shares of Concentra Group Holdings Parent?

Shares of CON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concentra Group Holdings Parent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concentra Group Holdings Parent investors own include Skye Bioscience (SKYE), CervoMed (CRVO), Core Scientific (CORZ), ChargePoint (CHPT), Carnival Co. & (CCL), Carrier Global (CARR) and Bit Digital (BTBT).

Company Calendar

• Last Earnings: 5/07/2025
• Record date for 5/29 Dividend: 5/20/2025
• Ex-Dividend for 5/29 Dividend: 5/20/2025
• Dividend Payable: 5/29/2025
• Today: 7/14/2025
• Next Earnings (Confirmed): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CON
• Previous Symbol: NYSE:CON
• CIK: 2014596
• Web: N/A
• Phone: (717) 972-1100
• Fax: N/A
• Employees: 11,250
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Concentra Group Holdings Parent: $28.50
• High Price Target: $32.00
• Low Price Target: $25.00
• Potential Upside/Downside: +43.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.34
• Trailing P/E Ratio: 14.84
• Forward P/E Ratio: 13.53
• P/E Growth: 1.77
• Net Income: $166.54 million
• Net Margins: 8.09%
• Pretax Margin: 11.37%
• Return on Equity: 29.94%
• Return on Assets: 6.31%

Debt

• Debt-to-Equity Ratio: 5.18
• Current Ratio: 1.10
• Quick Ratio: 1.10

Sales & Book Value

• Annual Sales: $1.90 billion
• Price / Sales: 1.34
• Cash Flow: $1.85 per share
• Price / Cash Flow: 10.77
• Book Value: $2.20 per share
• Price / Book: 9.04

Miscellaneous

• Outstanding Shares: 128,170,000
• Free Float: 119,713,000
• Market Cap: $2.55 billion
• Optionable: N/A
• Beta: N/A